Furthermore, HIF-1 has the capacity to promote lipid droplet accumulation and enhance cancer cell viability under hypoxic conditions by directly targeting AGPAT2, an enzyme crucially involved in the glycerophospholipid/triacylglycerol biosynthesis pathway (Triantafyllou et al., 2018). Here, AGPAT2 is linked to cancer.